Please login to the form below
Your new goal for communications – social impact
By Chris Bath
The future of healthcare professional engagement
By Ilana Scholl
Using consensus to drive clarity
By Derek Annan
Longevity lessons
The secret to corporate longevity isn’t growth, it’s survival
Are we the masters or servants of omnichannel engagement?
That ‘don’t’ impress me much
Digital Intelligence
Discovering the unique power of DOLs – are you harnessing the power of pharma’s new educators?By Akarsh Sakalaspur
What if pharma engaged its customers like Netflix or Amazon?By Lorraine Walters
The Editors
Jeux sans frontièresFrom regulations to customs, 2018 has some big questions to answer
Can NICE deliver on its funding promises?The Institute is now half-way thorugh its Cancer Drugs Fund reappraisals
Are we the masters or servants of omnichannel engagement?
That ‘don’t’ impress me muchDarwin's Medicine
Longevity lessonsThe secret to corporate longevity isn’t growth, it’s survival
Born strategic – Why great strategists are both born and made
Ad Lib
Dig deep: turning emotion into actionLife's Reg Manser gives his take on three recent disease awareness campaigns for charities
Ads with biteJaw-dropping ads from around the world
Euro'vision
PRIME Time in the EUNew pathway promises expedited approvals for innovative medicines
- Europe's market access outlook
An ever-closer union?
Subscribe to our email news alerts
Featured jobs
- Business Development Director, Medical Education - exciting new ...
-
Up to £120K base
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Associate Vice President, Scientific Services, Medical Communica...
-
Highly competitive salary
- Scientific Team Leader, Scientific Services, Medical Communicati...
-
Highly competitive salary
- Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit
- Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study
- Amylyx’s Relyvrio receives FDA approval for ALS treatment
- Janssen’s Erleada combination accepted in Scotland for prostate cancer
- Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis
- AstraZeneca’s Tezspire receives MHRA approval as add-on treatment for severe asthma
- Medscape Medical Affairs
- Envision Pharma Group appoints Head of Envision Value & Access
- How AI is finally helping rare diseases gain more than just attention
- WHO unveils new initiative to halt spread of invasive malaria vector in Africa
- NHS England launches lung cancer awareness drive in country’s cancer hotspots
- InflaRx seeks FDA authorisation for vilobelimab for critically ill COVID-19 patients
- COVID-19 linked to long-term neurologic disorders in new US study
- Pfizer and Sangamo Therapeutics reopen recruitment for haemophilia A gene therapy trial
- WHO unveils new initiative to halt spread of invasive malaria vector in Africa
- EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment
- Lilly’s Retevmo approved by FDA for RET fusion+ advanced/metastatic solid tumours
- Merck bags NICE recommendation for renal cell carcinoma adjuvant treatment
Latest intelligence
- How AI is finally helping rare diseases gain more than just attention
- By Neil Thompson...
- Is communication failing us?
- Compelling people to care in a world oversaturated with news and information...
- Are your field teams ready to excel in the new era?
- A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
